Lingohr Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Lingohr Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$205K	Buy	+5,871	New	+$204K	0.36%	91

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lingohr Asset Management's COLL Position: Q3 2025 in Review

Lingohr Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q3 2025: 5,871 shares worth $205K. The stake represents 0.36% of the portfolio and ranks #91 among its holdings.

244 funds tracked by Wall St. Rank hold COLL as of Q3 2025.

Lingohr Asset Management held 5,871 shares of Collegium Pharmaceutical worth $205K as of Q3 2025.
Collegium Pharmaceutical was a new Lingohr Asset Management position in Q3 2025.
Collegium Pharmaceutical made up 0.36% of Lingohr Asset Management's portfolio in Q3 2025, its #91 holding.
244 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2025.

Based on Lingohr Asset Management's 13F filing for Q3 2025, filed 4 Nov 2025.